The Charlotte Maxeke Johannesburg Academic Hospital is an accredited general hospital in Parktown, Johannesburg, Gauteng, South Africa.

There are 1 088 beds in Charlotte Maxeke Johannesburg Academic Hospital.

During the past decade, Charlotte Maxeke Johannesburg Academic Hospital conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 7 clinical trials were completed, i.e. on average, 31.8% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 1 clinical trials were completed. i.e. 9.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Charlotte Maxeke Johannesburg Academic Hospital" #1 sponsor was "Pfizer" with 9 trials, followed by "University of Witwatersrand, South Africa" with 6 trials sponsored, "Professor Francois Venter" with 4 trials sponsored, "Sangart" with 2 trials sponsored and "Willem Daniel Francois Venter" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Charlotte Maxeke Johannesburg Academic Hospital" #1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator, "Bill and Melinda Gates Foundation" with 1 trials as a collaborator, "Cancer International Research Group (CIRG)" with 1 trials as a collaborator, "Chugai Pharmaceutical" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Charlotte Maxeke Johannesburg Academic Hospital" are "HIV-1-infection" (3 trials), "Hemophilia A" (3 trials), "Hemophilia B" (3 trials), "Rheumatoid Arthritis" (3 trials) and "Acidosis, Lactic" (2 trials). Many other conditions were trialed in "Charlotte Maxeke Johannesburg Academic Hospital" in a lesser frequency.

Most popular intervention types in "Charlotte Maxeke Johannesburg Academic Hospital" are "Drug" (22 trials), "Biological" (5 trials), "Other" (3 trials), "Radiation" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (2 trials), "Cisplatin" (2 trials), "MP4OX" (2 trials), "PF-06741086" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Charlotte Maxeke Johannesburg Academic Hospital" are 22 trials for "All" genders, 5 trials for "Male" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Charlotte Maxeke Johannesburg Academic Hospital". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Charlotte Maxeke Johannesburg Academic Hospital, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Charlotte Maxeke Johannesburg Academic Hospital, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".